Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hypersensitivity × Cetirizine × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Uterine Cervical Neoplasms 1 Ovarian Neoplasms 1 Oncology Patients Receiving Chemotherapy 1 Neoplasms 1 Lung Neoplasms 1 Hypersensitivity 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Breast Neoplasms 1

Interventions

iniparib 2 Poly(ADP-ribose) Polymerase Inhibitors 2 Dexamethasone 2 amminedichloro(2-methylpyridine)platinum(II) 1 Rituximab 1 Lenalidomide 1 Cetirizine 1 Calcium Dobesilate 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06039137 2024-09-25

H1-Switch

Erasmus Medical Center

Hypersensitivity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡